SEC Form 4 · accession 0001104659-19-005606
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew M. Oh
Officer — Chief Financial Officer
Period of report
Jan 31, 2019
Accepted (ET)
Feb 4, 2019 · 6:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.69 | Jan 31, 2019 | A | 115,000 | A | — | Jan 30, 2029 | Common Stock | 115,000 | 115,000 | D |
Explanation of responses
- F125% of this option shall vest on January 31, 2020, then in 12 equal quarterly installments thereafter.